Connect with us
European Gaming Congress 2024

Fintech PR

Global Tinted Glass Market Expected to Reach US$ 41.26 Billion by 2033 with a 6.6% CAGR | Future Market Insights, Inc.




The construction and interior design sectors drive demand for tinted glass, with new trends like French green and crystal grey contributing. Tinted glass offers enhanced safety, security, and energy efficiency, fueling the market growth.

NEWARK, Del., Sept. 18, 2023 /PRNewswire/ — The tinted glass market is anticipated to expand its roots at a steady CAGR of 6.6% between 2023 and 2033. The market is anticipated to surpass US$ 41.26 billion by 2033, while it is likely to be valued at US$ 21.77 billion in 2023.


Request to Download Sample Summary to Get a Closer Look at Opportunities:

Tinted Glass Trends: Fueling Demand in Construction, Safety, Efficiency, and Innovation for UV Protection

  • The new construction and interior design businesses fuel the demand for tinted glass solutions. Furthermore, new experiments such as French green, crystal grey, and euro grey tinted float glass are increasing the demand for tinted glass.
  • The enhanced safety and security delivered through tinted glasses is flourishing the market growth. Furthermore, increased efficiency due to the lower energy consumption is anticipated to the market growth.
  • The advanced glassing solution and low-maintenance glasses are further expected to boost the demand for tinted laminate glass. Alongside, tinted smart glass is also in high demand, expanding the tinted glass market size.
  • Many corporate and residential setups are adopting tinted glasses solutions for high UV protection.   

Key Points from the Tinted Glass Market Research Report:

  1. The United States market leads the tinted glass market in terms of sales volume in North America. The market holds a market share of 13.4% in 2023. The market growth is attributed to the increased number of corporate systems adopting glasses that protect them from sunlight and ultraviolet rays.
  2. India’s tinted glass market leads the South Asia market in terms of CAGR with a leading CAGR of 8.0% between 2023 and 2033. The regional growth is attributed to growing awareness among people about the hazardous effects of UV rays
  3. On the other hand, China’s tinted glass market flourishes at a CAGR of 8.1% between 2023 and 2033. The rising number of industrial warehouses with product stores are adopting tinted glass solutions.
  4. By thickness, 6 mm tinted glass is in high demand as it is in high consumption due to the perfect size for different settings like residential, office buildings, and even grocery stores.
  5. By color, the grey segment leads while holding a prominent market share of 40.7% in 2023.

Explore the Research Methodology behind the Tinted Glass Market Research Study:

Competitive Landscape:

The key vendors work on producing the best quality glasses with experimentation and production value. Furthermore, the companies also provide application-specific tinted glass solutions.  Key competitors also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel.

The key players in the market are

  • AGC Inc.
  • Saint-Gobain
  • Nippon Sheet Glass Co., Ltd.
  • Vitro
  • Xinyi Glass Holdings Limited
  • Guardian Industries Corp.
  • Taiwan Glass Group, Ltd
  • Shanghai Yaohua Pilkington Glass Group Co., Ltd
  • Qingdao Rexi Industries Co. Ltd.

Recent Market Developments

–  Guardian Industries Corp has introduced its guardian tinted glass that delivers solutions to exterior facades and interior decors.  It comes for homes as well as commercial businesses. The tint also comes in various colors and designs.

–  Taiwan Glass Group, Ltd. has revisited its tinted glass and updated its packaging and build quality. The company will likely hold a good amount of traction in the future. 


Unlock a wealth of insights with our comprehensive report, providing you access to an in-depth breakdown of market structure, strategy, and product portfolios! Purchase now:

About the Author:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.


Adjacent Research Reports:

  1. Glass Fiber Reinforced Plastic (GFRP) Composites Market is predicted to capture a valuation of US$ 18.54 billion in 2023 and rise to US$ 41.53 billion by 2033. The market is estimated at a CAGR of 8.4% during the forecast period.
  2. Glass Additives Market will reach US$ 1.4 Billion by the end of 2022. In the long run, from 2022-2032, the market is expected to flourish at a 4.2% CAGR, reaching US$ 2.1 Billion.
  3. Residential and commercial Smart Glass Market is projected to reach approximately US$ 14 Billion by 2028, at an estimated CAGR of more than 15% over 2018-2028.
  4. Fiberglass Market is predicted to rise at a CAGR of 4.3% over the forecast period (2022-2028) and reach a valuation of US$ 13.1 Billion by 2028, up from the current market size of US$ 10.2 Billion.
  5. Silica Sand for Glass Making Market is expected to be valued at US$ 5.7 billion in 2023. As per the research, the market is expected to register a CAGR of 4.1% between 2023 and 2033. The valuation is projected to cross US$ 8.5 billion by 2033.
  6. Borosilicate Glass Market is expected to surge from US$ 2.03 Billion in 2022 to US$ 4 Billion in 2032. The industry is projected at a CAGR of 7% during the forecast period from 2022 to 2032.
  7. Glass Additives Market was valued at US$ 1.3 Billion in 2021 and is likely to reach US$ 1.4 Billion by the end of 2022. In the long run, from 2022-2032, the market is expected to flourish at a 4.2% CAGR, reaching US$ 2.1 Billion.
  8. The European silica Sand for Glass sand-making market is predicted to cross a valuation of US$ 1,107.3 million in 2023. It is estimated to attain a valuation of US$ 1,654.9 million by 2033. The market is predicted to thrive at a CAGR of 4.1% from 2023 to 2033.
  9. Insulated Glass Market is projected to be valued at US$ 13.4 Billion in 2022, and it is set to reach US$ 22.8 Billion in 2032 and exhibit rapid growth at a CAGR of 7.5% in the forecast period from 2022 to 2032.
  10. The heat-resistant glass market analysis report released by FMI estimates the current revenue generated by sales of this product worldwide to be around US$ 4.8 Billion. Further, by the year 2032, the net worth of the global heat-resistant glass is predicted to be around US$ 7.5 Billion and is predicted to register a fair CAGR of 4.3% through these forecast years.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: 

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
[email protected]
LinkedInTwitterBlogs | YouTube



Logo –

Cision View original content:–future-market-insights-inc-301930645.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting


The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision


The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895


EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”


Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.


BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading

Latest news